Q4 2024 Procept Biorobotics Corp Earnings Call Transcript
Key Points
- PROCEPT BioRobotics Corp (PRCT) reported a 57% increase in total revenue for Q4 2024 compared to Q4 2023, driven by increased robot sales and procedures.
- The company achieved a 60% growth in the US installed base, with 505 systems by the end of 2024.
- The introduction of the Hydro robotic system, featuring advanced AI and ultrasound integration, has been well-received, leading to a robust capital pipeline.
- International revenue grew by 137% in Q4 2024, with strong sales momentum in the United Kingdom.
- Gross margin for Q4 2024 reached an all-time high of 64%, attributed to improved operational efficiencies and higher average selling prices.
- A saline shortage due to Hurricane Helene impacted Q4 2024 procedures, resulting in a delay or cancellation of up to 2000 expected procedures.
- Operating expenses for Q4 2024 exceeded guidance by approximately 3.5%, primarily due to higher variable compensation expenses.
- The company experienced a net loss of $18.9 million for Q4 2024, although this was an improvement from the previous year.
- The transition to the new Hydro system required significant training efforts, which initially impacted sales force productivity.
- Despite strong growth, PROCEPT BioRobotics Corp (PRCT) still holds only about 10% of the US BPH receptive market share, indicating a long runway for further market penetration.
Good afternoon and welcome to Procept Biorobotics fourth quarter and year-end 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Matt Baxo, Vice President, Investor Relations for a few introductory comments.
Good afternoon and thank you for joining Procept Biorobotics fourth quarter and year-end 2024 earnings conference call. Presenting on today's call are Reza Zadno, Chief Executive Officer; Kevin Waters, Chief Financial Officer; and Shamsha Black, Chief Commercial Officer.
Before we begin, I'd like to remind listeners that statements made on this conference call that relate to future plans, events, or performance are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1,995. All these forward-looking statements are based on management's current expectations and beliefs. These statements are subject to several risks, uncertainties,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
